Series C funding round for Amplyx Pharmaceuticals raising $53M in May 2020
Series C funding round for Amplyx Pharmaceuticals raising $53M in May 2020
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Ed Mathers |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$172.6M
Top Valuation
-
Amplyx Pharmaceuticals raised $53M in a Series C round.
The round was announced on 05/01/20.
The round was led by Sofinnova Ventures.